[EN] MORPHINAN DERIVATIVES AND COMPOSITIONS COMPRISING THE SAME FOR TREATING AUTOIMMUNE, INFLAMMATION OR INFECTION RELATED DISORDERS<br/>[FR] DÉRIVÉS DE MORPHINANE ET COMPOSITIONS LES COMPRENANT POUR TRAITER DES TROUBLES AUTO-IMMUNS, INFLAMMATOIRES OU INFECTIEUX
申请人:TAIWANJ PHARMACEUTICALS CO LTD
公开号:WO2018128798A1
公开(公告)日:2018-07-12
Novel antagonists of toll-like receptor 4 (TLR-4) are provided. More specifically, the novel antagonists of TLR-4 are derived from morphinan. Further, use of said morphinan derivatives in the treatment of diseases and/or disorders mediated by TLR-4, such as autoimmune diseases, inflammation disease and infectious diseases, is provided. Pharmaceutical compositions including said morphinan derivatives are also provided.
提供了新型Toll样受体4(TLR-4)拮抗剂。更具体地说,这些新型TLR-4拮抗剂源自吗啡类化合物。此外,提供了利用这些吗啡类衍生物治疗由TLR-4介导的疾病和/或疾病的方法,如自身免疫疾病、炎症性疾病和传染病。还提供了包含这些吗啡类衍生物的药物组合物。